Table 4.
COVID-19 outcomes in the IEI Cohort and effect of vaccination. Data are presented as column totals/percentages for outcomes of infection, and hospitalization, ICU admission, and death among those infected.
| IEI patient with ≥ 1 COVID-19 infection | N = 823 | P | |
|---|---|---|---|
| asymptomatic | 64 (7.8%) | ||
| acute | 734 (89.2%) | ||
| MIS-C/MIS-A | 7 (0.8%) | ||
| long | 13 (1.6%) | ||
| other | 5 (0.6%) | ||
| Required hospitalization for COVID-19 infection | N = 156 (19.0%) | P < 0.001 | |
| history of ≥ 1 vaccine prior to hospitalization | 20 (12.8%) | ||
| no vaccination prior to hospitalization | 132 (84.6%) | ||
| vaccinated but unknown timing relative to hospitalization | 4 (2.6%) | ||
| Required ICU stay for COVID-19 infection | N = 47 (5.7%) | P < 0.001 | |
| history of ≥ 1 vaccine prior to ICU | 6 (12.8%) | ||
| no vaccination prior to ICU | 41 (87.2%) | ||
| vaccinated but unknown timing relative to ICU stay | 0 (0%) | ||
| Died in association with COVID-19 infection | N = 28 (3.4%) | P < 0.001 | |
| history of ≥ 1 vaccine prior to death | 5 (17.9%) | ||
| no vaccination prior to death | 23 (82.1%) | ||
| vaccinated but unknown timing relative to death | 0 (0%) |